|Dr. Michael Monsour M.D., MBBS-HONS, FACRRM,FAICD||Exec. Chairman||N/A||N/A||N/A|
|Mr. Geoff Daly BE (Hons, Mech, UQ), MBA (Exec, AGSM), MIEAust CPE||Chief Exec. Officer||N/A||N/A||N/A|
|Mr. Ross Mangelsdorf B.Bus, FCA, CTA, FTIA, MAICD||Chief Financial Officer and Exec. Director||N/A||N/A||N/A|
|Mr. Bryan Dulhunty BEc, ACA||Company Sec.||N/A||N/A||N/A|
Analytica Limited designs, develops, and supplies medical devices in Australia. Its lead product is the PeriCoach System, an e-health treatment system for women who suffer stress urinary incontinence. PeriCoach comprises a device, Web portal, and smartphone app for evaluating activity in pelvic floor muscles. The company also engages in developing intellectual property of medical device, ELF2, to assist neurologists and rehabilitate the treatment of muscular spasticity. In addition, it provides AutoStart Infusion System that contains an enhanced float device that automatically restarts IV fluid flow following infused delivery of the predetermined amount of medication. Analytica Limited is based in Brisbane, Australia.
Analytica Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.